Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation.

Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation. Abstract Text:

R Wulkow,J-M Vix,C Schuijt,H Peil,M A Kamm,C Jordan,R Wulkow,J-M Vix,C Schuijt,H Peil,M A Kamm,C Jordan,

There are few studies supporting the effective and safe use of laxatives for constipation. This study examined the short-term efficacy and safety of sodium picosulphate in patients with chronic constipation. Patients with a history of chronic constipation for at least 3 months were randomised to receive 7 mg sodium picosulphate or placebo for three consecutive nights. Patients recorded stool frequency and consistency, straining, bloating, and pain at baseline and during treatment. Vital signs, haematocrit, serum creatinine and electrolytes were monitored. Primary end-point for efficacy was the occurrence of a response to treatment, defined as improvement in stool frequency and occurrence of straining. All 57 randomised patients (sodium picosulphate n = 29, placebo n = 28; mean age 54.8 and 54.1 years) completed the study. Sodium picosulphate produced a treatment response (improved stool frequency and straining) in 82.8% compared with 50% in the placebo group (p = 0.010) and reduced bloating more often than placebo. There were no serious adverse events and one patient with diarrhoea and another with abdominal pain in each treatment group. There were no cardiovascular effects, changes in serum haematocrit, creatinine or electrolytes in either group. This study confirmed that sodium picosulphate is an effective, well-tolerated and safe laxative in the acute treatment of constipation.

Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation. Publishing Authors By Initials

R Wulkow,JM Vix,C Schuijt,H Peil,MA Kamm,C Jordan,R Wulkow,JM Vix,C Schuijt,H Peil,MA Kamm,C Jordan,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: International journal of clinical practice

VOLUME: 61

Page Numbers: 944-50

Journal Abbreviation: Int. J. Clin. Pract.

ISSN: 1368-5031

DAY: 16

MONTH: Jun

YEAR: 2007

Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9712381

Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation.

AFFILIATION: Quintiles GmbH, Freiburg, Germany.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Clin Pract

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation Related Publications

• 2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules.
• A laser-temperature-jump method for the study of the rate of transfer of hydrophobic ions and carriers across the interface of thin lipid membranes.
• Acetylphosphinate is the most potent mechanism-based substrate-like inhibitor of both the human and Escherichia coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex.
• Androgen-sensitivity of somata and dendrites of spinal nucleus of the bulbocavernosus (SNB) motoneurons in male C57BL6J mice.
• Beyond raloxifene for the prevention of osteoporosis and breast cancer.
• Cooperative effect of gefitinib and fumitremorgin c on cell growth and chemosensitivity in estrogen receptor alpha negative fulvestrant-resistant MCF-7 cells.
• Current noise in transport of hydrophobic ions through lipid bilayer membranes including diffusion polarization in the aqueous phase.
• Development of a one-step immunocapture real-time TaqMan RT-PCR assay for the broad spectrum detection of Pepino mosaic virus.
• Dexamethasone in acute bacterial meningitis.
• Effect of raloxifene on salivary sex steroid concentrations in premenopausal women.
• Effects of the testicular feminization mutation (tfm) of the androgen receptor gene on BSTMPM volume and morphology in rats.
• Function of a conserved loop of the beta-domain, not involved in thiamin diphosphate binding, in catalysis and substrate activation in yeast pyruvate decarboxylase.
• Interpretation of serum C-reactive protein (CRP) levels for cardiovascular disease risk is complicated by race, pulmonary disease, body mass index, gender, and osteoarthritis.
• Leaf maximum photosynthetic rate and venation are linked by hydraulics.
• Molecular basis of acute intermittent porphyria.
• Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial.
• Origin and evolution of human microRNAs from transposable elements.
• Peripheral endothelin A receptor antagonism attenuates carcinoma-induced pain.
• Racial disparity in stage at diagnosis and survival among adults with oral cancer in the US.
• Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation.
• Relationship of limb length inequality with radiographic knee and hip osteoarthritis.
• Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
• SERMs: meeting the promise of multifunctional medicines.
• Spirituality and depressive symptoms in a racially diverse US sample of community-dwelling adults.
• Steroid receptors and their role in the biology and control of breast cancer growth.
• Synthesis with good enantiomeric excess of both enantiomers of alpha-ketols and acetolactates by two thiamin diphosphate-dependent decarboxylases.
• The 1',4'-iminopyrimidine tautomer of thiamin diphosphate is poised for catalysis in asymmetric active centers on enzymes.
• Tuning a potassium channel--the caress of the surroundings.
• Use of polymerase chain reaction as a diagnostic tool for neonatal sepsis can result in a decrease in use of antibiotics and total neonatal intensive care unit length of stay.
• Validity and factor structure of the AUSCAN Osteoarthritis Hand Index in a community-based sample.